期刊文献+

慢性盆腔炎经桂枝茯苓胶囊与克拉霉素中西医治疗的效果观察 被引量:7

Chronic pelvic inflammatory disease treated by Guizhi Fuling Capsule and clarithromycin in Chinese and Western Medicine
下载PDF
导出
摘要 目的分析中西医方法用于妇产科慢性盆腔炎临床治疗中的效果。方法回顾性分析2017年1月至2018年1月本院妇产科慢性盆腔炎患者94例,依据临床治疗方法分为观察组、对照组各47例,分别接受桂枝茯苓胶囊联合克拉霉素缓释胶囊治疗、克拉霉素缓释胶囊单一治疗,比较两组效果。结果观察组治疗后总有效率为93.62%,对照组治疗后总有效率76.60%;观察组治疗后hs-CRP、血沉、红细胞比容测定结果均明显低于对照组(P<0.05)。结论慢性盆腔炎妇产科治疗中应用克拉霉素联合桂枝茯苓胶囊可以帮助患者炎症反应得到有效改善,获得更高的临床效果,值得在临床进行推广。 Objective Analysis of the effect of traditional Chinese and Western Medicine in the treatment of Obstetrics and Gynecology chronic pelvic inflammatory Disease. Methods A retrospective analysis of 94 patients with chronic pelvic inflammatory disease in gynecology and obstetrics from January 2017 to January 2018 was performed. According to the clinical treatment methods, 94 patients were divided into two groups: the observation group(n=47) and the control group(n=47), which were treated with Guizhi Fuling capsule and clarithromycin sustained release capsule respectively. Clarithromycin sustained release capsule was used to treat the patients. Results The total effective rate was 93.62% in the observation group and 76.60% in the control group, and the results of hs-CRP, erythrocyte sedimentation rate and erythrocyte volume in the observation group were significantly lower than those in the control group(P<0.05). Conclusion The application of clarithromycin combined with Guizhi Fuling capsule in the treatment of chronic pelvic inflammation in obstetrics and gynecology can effectively improve the inflammatory reaction of the patients and obtain higher clinical effect, which is worth popularizing in clinic.
作者 陈良方 陈丽 Chen Liangfang;Chen Li(Qichun Third people' s hospital, Huanggang, Hubei, 435300, China)
出处 《当代医学》 2019年第14期115-117,共3页 Contemporary Medicine
关键词 慢性盆腔炎 妇产科 治疗 Chronic pelvic inflammation Obstetrics and Gynecology Treatment
  • 相关文献

参考文献12

二级参考文献118

共引文献258

同被引文献55

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部